Treatment for frequent trauma-related nightmares
Exposure, Relaxation, Rescripting Therapy (ERRT) Dismantling
This study is testing a new therapy to see if it can help people with frequent trauma-related nightmares feel better and sleep more soundly.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Tulsa Academic / other |
| Locations | 1 site (Tulsa, Oklahoma) |
| Trial ID | NCT02236377 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of Exposure, Relaxation, and Rescripting Therapy (ERRT) for individuals suffering from frequent trauma-related nightmares. The study aims to understand the dose effect and mechanisms of change associated with this psychological intervention, which has shown promise in reducing nightmare frequency and intensity, as well as improving sleep quality. Participants will undergo a series of treatments while their progress and outcomes will be closely monitored to gather data on the therapy's efficacy. The study builds on previous findings that suggest ERRT can also alleviate symptoms of PTSD and depression.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have experienced a traumatic event and suffer from frequent nightmares.
Not a fit: Patients with acute psychosis, untreated substance use disorders, or severe mental health issues such as active suicidality may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from trauma-related nightmares and associated symptoms.
How similar studies have performed: Previous studies have shown promising results for ERRT in reducing nightmares and improving sleep quality, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older at the time of the intake, * experienced a traumatic event, as defined by the Diagnostic and Statistical Manual (DSM-5), * have approximately one nightmare each week for the past month * be able to read and speak English. Exclusion Criteria: * age of 17 or younger * acute or apparent psychosis * unmedicated bipolar disorder * intellectual disability * active suicidality, * recent parasuicidal behaviors * untreated substance use disorder in past 6 months
Where this trial is running
Tulsa, Oklahoma
- Joanne L. Davis — Tulsa, Oklahoma, United States (Recruiting)
Study contacts
- Principal investigator: Joanne L Davis, PhD — University of Tulsa
- Study coordinator: Joanne L Davis, PhD
- Email: joanne-davis@utulsa.edu
- Phone: 9186312875
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.